首页> 外国专利> THERAPIES FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH ABNORMAL EXPRESSION OF A NEURAL-ASSOCIATED GENE

THERAPIES FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH ABNORMAL EXPRESSION OF A NEURAL-ASSOCIATED GENE

机译：治疗与神经相关基因异常表达相关的疾病和疾病的疗法

页面导航

摘要
著录项
相似文献

摘要

The disclosure provides methods for rescuing synaptic defects caused by abnormal MeCP2 expression in a subject in need thereof, comprising administering to the subject therapeutically effective amount(s) of a nootropic agent and/or an alpha-7 nicotinic acetylcholine receptor (α7-nAChR) agonist. The disclosure further provides methods for screening candidate drug candidates in a tiered series of assays and models (neurons, MECP2-mosaic neurospheres, and cortical organoids).

机译：本公开提供了用于借用有此需要的受试者中的MECP2表达异常引起的突触缺陷的方法，包括向受试者施用治疗有效量和/或α-7烟酰基乙酰胆碱受体（α7-NACHR）激动剂。本公开内容还提供了用于筛选候选药物候选物中的分层测定和模型（神经元， MECP2-I> - 墨西神经光学器和皮质有机体）的方法。 展开▼

著录项

公开/公告号WO2021168110A1

专利类型

公开/公告日2021-08-26

原文格式PDF

申请/专利权人 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;
展开▼

申请/专利号USUS2021/018573

发明设计人 MUOTRI ALYSSON RENATO;TRUJILLO CLEBER;
展开▼

申请日2021-02-18

分类号A61K31;A61P25;A61P25/28;

国家 US

入库时间 2022-08-24 20:49:52

相似文献

专利

外文文献

中文文献

1. 神经毒素疗法在泌尿系及相关疾病治疗中的应用 [P] . 中国专利： CN1480212B . 2013.12.04

2. 神经毒素疗法在泌尿系及相关疾病治疗中的应用 [P] . 中国专利： CN1803189B . 2010.05.26

3. Methods of reducing the possibility of mortality in an animal, virulent expression in an intestinal pathogen, and adhesin / lectin pa-i expression in a bacterial cell, inhibiting adhesin / lectin pa-i expression in an intestinal pathogen, intestine-induced activation of adhesin / lectin pa-i, c4-hsl-induced morphological change of an intestinal pathogen, and bacterial cell adhesion in a mammalian intestine, improvement of intestinal pathogenesis, disease prevention or abnormal condition, skin and respiratory infection, sexually transmitted disease, digestive tract disorder, loss of lactating capacity in an animal, and development of a microbe-mediated epithelial disorder in a nursing-age animal, irrigation of at least a portion of the urinary tract, and for monitoring the administration of poly (ethylene glycol) (peg) to an animal, composition pharmaceuticals, kits for the prevention or therapeutic treatment of bowel-derived sepsis, and for monitoring the administration of poly (ethyle [P] . BR0215954A . 2005-09-13

机译：减少动物死亡，肠道病原体中强毒表达以及细菌细胞中粘附素/凝集素pa-i表达，抑制肠道病原体中粘附素/凝集素pa-i表达，肠道诱导的粘附素活化的方法/凝集素pa-i，c4-hsl诱导的肠道病原体形态变化和哺乳动物肠道细菌细胞粘附，改善肠道发病机制，预防疾病或异常状况，皮肤和呼吸道感染，性传播疾病，消化道疾病，动物泌乳能力的丧失以及哺乳期动物中微生物介导的上皮疾病的发展，至少一部分尿路的冲洗以及用于监测聚乙二醇（peg）的给药动物，组合物药物，用于预防或治疗肠源性败血症并监测多乙

4. METHODS FOR TREATING A PATIENT HAVING A DISEASE OR DISORDER, To treat a patient with autoimmune disease, TO NEUTRALIZE A TYPE 1 IFN INDUCIBLE PD MARKER EXPRESSION PROFILE OR IFNALFA IN A PATIENT, FOR MONITORING OR PROGNOSTICING A PATIENT'S AUTOIMMUNE DISEASE PROGRESS, TO MONITOR DISEASE PROGRESS OF A PATIENT RECEIVING TREATMENT WITH A THERAPEUTIC AGENT CONNECTING TO AND MODULATING IFNALFA'S ACTIVITY, TO IDENTIFY A PATIENT AS A CANDIDATE FOR A THERAPEUTIC AGENT CONNECTING AND MODULATING IFNALFA'S ACTIVITY, TO DIAGNOSE A PATIENT AS HAVING A DISTRESS ASSOCIATED WITH INCREASED IFNALFA LEVELS, TO IDENTIFY A CANDIDATE THERAPY FOR THE TREATMENT OF IFNALFA-MEDIATED DISORDERS AND TO DETECT IFN ACTIVITY IN A SAMPLE, Probe Set, AND, KIT [P] . BRPI0720035A2 . 2019-05-07

机译：治疗患有疾病或疾病的患者，治疗自身免疫性疾病的患者，中和患者的1型IFN诱导型PD标记表达谱或IFNα的方法，以监测或预知患者的自身疾病病情进展，接受与INFALFA活性相关的治疗性治疗的患者的治疗，以鉴定与治疗和治疗INFALFA的病历有关的患者作为候选者，对患者的病情进行诊断，以便对患者的病情进行诊断在样品，探针组和试剂盒中进行候选疗法治疗IFNα介导的疾病并检测IFN的活性

5. Methods for the detection of a disease or disorder in a angiogu00eanico indivu00ecduo, for the detection of C u00e1 NCER in a indivu00ecduo, for the treatment of a indivu00ecduo affected with a disease or disorder angiogu00eanico, for determining the probability of effectiveness of antihypertensive therapy angiog u00eanica,To determine the efficacy of a therapy to test in the modulation of angiogenic regulators nu00ecveis platelet, for the creation of a record or profile of platelet to a disease or disorder angiogu00eanico and for monitoring the efficacy of a therapy in a indivu00ecduo with u. A disease or disorder angiogu00eanico [P] . BRPI0510266A . 2007-10-30

机译：用于检测个体血管疾病的方法，检测个体NCER的方法，用于治疗患有疾病血管疾病的个体的方法，用于确定抗高血压治疗血管生成素的有效性的可能性，用于确定在调节血管生成调节剂n ecveis血小板中进行测试的疗法的有效性，用于创建针对疾病或紊乱血管生成血小板的记录或特征并用于监测具有u的个体治疗的疗效。一种疾病或血管疾病

1. Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders:is the escape from senescence an answer? [J] . Alessandro Castorina, Marta Anna Szychlinska, Rubina Marzagalli, 中国神经再生研究（英文版） . 2015,第006期

2. Efficacy of Yiqiyangxin Chinese medicine compound combined with cognitive therapy in the treatment of generalized anxiety disorders [J] . Ting Wang, Jing-Yuan Ding, Guang-Xing Xu, 亚太热带医药杂志（英文版） . 2012,第010期

3. Apolipoprotein A-V gene therapy for disease prevention / treatment: a critical analysis [J] . Trudy M.Forte, Vineeta Sharma, Robert O.Ryan 生物医学研究杂志（英文版） . 2016,第002期

4. A new method of EHF-therapy in the treatment of endogene mental diseases [C] . Derkach, V.N., Bacherikov, . 2000

5. Working towards an optimized therapy for abnormal endometrial proliferation: Treatment approaches and disease modeling. [D] . Almomen, Aliyah. 2016

6. Transcriptomic Analysis Reveals Abnormal Expression of Prion Disease Gene Pathway in Brains from Patients with Autism Spectrum Disorders [O] . Salvo Danilo Lombardo, Giuseppe Battaglia, Maria Cristina Petralia, 2020

7. Poster session 2Morphogenetic mechanisms290MiR-133 regulates retinoic acid pathway during early cardiac chamber specification291Bmp2 regulates atrial differentiation through miR-130 during early heart looping formationDevelopmental genetics294Association of deletion allele of insertion/deletion polymorphism in alpha 2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus295Association of G1359A polymorphism of the endocannabinoid type 1 receptor (CNR1) with coronary artery disease (CAD) with type 2 diabetes mellitusCell growth, differentiation and stem cells - Vascular298Gamma-secretase inhibitor prevents proliferation and migration of ductus arteriosus smooth muscle cells: a role of Notch signaling in postnatal closure of ductus arteriosus299Mesenchymal stromal-like cells (MLCs) derived from induced pluripotent stem (iPS) cells: a promising therapeutic option to promote neovascularization300Sonic Hedgehog promotes mesenchymal stem cell differentiation to vascular smooth muscle cells in cardiovacsular disease301Proinflammatory cytokine secretion and epigenetic modification in endothelial cells treated LPS-GinfivalisCell death and apoptosis - Vascular304Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipidsTranscriptional control and RNA species - Vascular307MicroRNA-34a role in vascular calcification308Local delivery of a miR-146a inhibitor utilizing a clinically applicable approach attenuates neointima formation after vascular injury309Long noncoding RNA landscape of hypoxic endothelial cells310Specific circulating microRNAs levels associate with hypertension, hyperglycemia and dysfunctional HDL in acute coronary syndrome patientsCytokines and cellular inflammation - Vascular313Phosphodiesterase5A up-regulation in vascular endothelium under pro-inflammatory conditions: a newly disclosed anti-inflammatory activity for the omega-3polyunsaturated aatty acid docosahexaenoic acid314Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid arthritis315Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation316Lymphocytic myocarditis coincides with increased plaque inflammation and plaque hemorrhage in coronary arteries, facilitating myocardial infarction317Serum osteoprotegerin level predictsdeclined numerous of circulating endothelial- derived and mononuclear-derived progenitor cells in patients with metabolic syndromeGrowth factors and neurohormones - Vascular320Effect of gastrin-releasing peptide (GRP) on vascular inflammationSignal transduction - Heart323A new synthetic peptide regulates hypertrophy in vitro through means of the inhibition of nfkb324Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy325Regulation of beta-adrenoceptor-evoked inotropic responses by inhibitory G protein, adenylyl cyclase isoforms 5 and 6 and phosphodiesterases326Binding to RGS3 and stimulation of M2 muscarinic acetylcholine receptors modulates the substrate specificity of p190RhoGAP in cardiac myocytes327Cardiac regulation of post-translational modifications, parylation and deacetylation in LMNA dilated cardiomyopathy mouse model328Beta-adrenergic regulation of the b56delta/pp2a holoenzyme in cardiac myocytes through b56delta phosphorylation at serine 573Nitric oxide and reactive oxygen species - Vascular331Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1 and eNOS332Antioxidant therapy prevents oxidative stress-induced endothelial dysfunction and Enhances Wound Healing333Morphological and biochemical characterization of red blood cell in coronary artery diseaseCytoskeleton and mechanotransduction - Heart336Novel myosin activator, JSH compounds, increased myocardial contractility without chronotropic effect in ratsExtracellular matrix and fibrosis - Vascular339Ablation of Toll-like receptor 9 causes cardiac rupture after myocardial infarction by attenuating proliferation and differentiation of cardiac fibroblasts340Altered vascular remodeling in the mouse hind limb ischemia model in Factor VII activating protease (FSAP) deficiencyVasculogenesis, angiogenesis and arteriogenesis343Pro-angiogenic effects of proly-hydroxylase inhibitors and their potential for use in a novel strategy of therapeutic angiogenesis for coronary total occlusion344Nrf2 drives angiogenesis in transcription-independent manner: new function of the master regulator of oxidative stress response345Angiogenic gene therapy, despite efficient vascular growth, is not able to improve muscle function in normoxic or chronically ischemic rabbit hindlimbs -role of capillary arterialization and shunting346Effect of PAR-1 inhibition on collateral vessel growth in the murine hind limb model347Quaking is a key regulator of endothelial cell differentiation, neovascularization and angiogenesis348"Emerging angiogenesis" in the chick chorioallantoic membrane (CAM). An in vivo study349Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis in vitro and in vivo via EMMPRINEndothelium352Reciprocal regulation of GRK2 and bradykinin receptor stimulation modulate Ca2+ intracellular level in endothelial cells353The roles of bone morphogenetic proteins 9 and 10 in endothelial inflammation and atherosclerosis354The contribution of GPR55 to the L-alpha-lysophosphatidylinositol-induced vasorelaxation in isolated human pulmonary arteries355The endothelial protective ACE inhibitor Zofenoprilat exerts anti-inflammatory activities through H2S production356A new class of glycomimetic drugs to prevent free fatty acid-induced endothelial dysfunction357Endothelial progenitor cells to apoptotic endothelial cell-derived microparticles ration differentiatesas preserved from reduced ejection fractionheart failure358Proosteogenic genes are activated in endothelial cells of patients with thoracic aortic aneurysm359Endothelin ETB receptors mediate relaxing responses to insulin in pericardial resistance arteries from patients with cardiovascular disease (CVD)Smooth muscle and pericytes362CX3CR1 positive myeloid cells regulate vascular smooth muscle tone by inducing calcium oscillations via activation of IP3 receptors363A novel function of PI3Kg on cAMP regulation, role in arterial wall hyperplasia through modulation of smooth muscle cells proliferation364NRP1 and NRP2 play important roles in the development of neointimal hyperplasia in vivo365Azithromycin induces autophagy in aortic smooth muscle cellsCoagulation, thrombosis and platelets368The real time in vivo evaluation of platelet-dependent aldosterone prothrombotic action in mice369Development of a method for in vivo detection of active thrombi in mice370The antiplatelet effects of structural analogs of the taurine chloramine371The influence of heparin anticoagulant drugs on functional state of human platelets372Regulation of platelet aggregation and adenosine diphosphate release by d dimer in acute coronary syndrome (in vitro study)Oxygen sensing, ischaemia and reperfusion375Sirtuin 5 mediates brain injury in a mouse model of cerebral ischemia-reperfusion376Abscisic acid: a new player in cardiomyocyte protection from ischaemia?377Protective effects of ultramicronized palmitoylethanolamide (PEA-um) in myocardial ischaemia and reperfusion injury in vivo378Identification of stem cell-derived cardiomyocytes using cardiac specific markers and additional testing of these cells in simulated ischemia/reperfusion system379Single-dose intravenous metformin treatment could afford significant protection of the injured rat kidney in an experimental model of ischemia-reperfusion380Cardiotoxicity of long acting muscarinic receptor antagonists used for chronic obstructive pulmonary disease381Dependence antioxidant potential on the concentration of amino acids382The impact of ischemia-reperfusion on physiological parameters,apoptosis and ultrastructure of rabbit myocardium with experimental aterosclerosisMitochondria and energetics385MicroRNA-1 dependent regulation of mitochondrial calcium uniporter (MCU) in normal and hypertrophied hearts386Mitochondrial homeostasis and cardioprotection: common targets for desmin and aB-crystallin387Overexpression of mitofusin-2 (Mfn2) and associated mitochondrial dysfunction in the diabetic heart388NO-dependent prevention of permeability transition pore (MPTP) opening by H2S and its regulation of Ca2+ accumulation in rat heart mitochondria389G protein coupled receptor kinase 2 (GRK2) is fundamental in recovering mitochondrial morphology and function after exposure to ionizing radiation (IR)Gender issues392Sex differences in pulmonary vascular control; focus on the nitric oxide pathwayAging395Heart failure with preserved ejection fraction develops when feeding western diet to senescence-accelerated mice396Cardiovascular markers as predictors of cognitive decline in elderly hypertensive patients397Changes in connexin43 in old rats with volume overload chronic heart failureGenetics and epigenetics400Calcium content in the aortic valve is associated with 1G>2G matrix metalloproteinase 1 polymorphism401Neuropeptide receptor gene s (NPSR1) polymorphism and sleep disturbances402Endothelin-1 gene Lys198Asn polymorphism in men with essential hypertension complicated and uncomplicated with chronic heart failure403Association of common polymorphisms of the lipoprotein lipase and pon1 genes with the metabolic syndrome in a sample of community participantsGenomics, proteomics, metabolomics, lipidomics and glycomics405Gene expression quantification using multiplexed color-coded probe pairs to determine RNA content in sporadic cardiac myxoma406Large-scale phosphorylation study of the type 2 diabetic heart subjected to ischemia / reperfusion injury407Transcriptome-based identification of new anti-inflammatory properties of the olive oil hydroxytyrosol in vascular endothelial cell under basal and proinflammatory conditions408Gene polymorphisms combinations and risk of myocardial infarctionComputer modelling, bioinformatics and big data411Comparison of the repolarization reserve in three state-of-the-art models of the human ventricular action potentialMetabolism, diabetes mellitus and obesity414Endothelial monocyte-activating polypeptide-II improves heart function in type -I Diabetes mellitus415Admission glucose level is independent predictor of impaired left ventricular function in patients with acute myocardial infarction: a two dimensional speckle-tracking echocardiography study416Association between biochemical markers of lipid profile and inflammatory reaction and stiffness of the vascular wall in hypertensive patients with abdominal obesity417Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening418Investigating the cardiovascular effects of antiretroviral drugs in a lean and high fat/sucrose diet rat model of obesity419Statins in the treatment of non-alcoholic steatohepatitis (NASH). Our experience from a 2-year prospective study in Constanta County, Romania420Epicardial adipose tissue as a predictor of cardiovascular outcome in patients with ACS undergoing PCI?Arterial and pulmonary hypertension423Dependence between heart rhythm disorers and ID polymorphism of ACE gene in hypertensive patients424Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension425Inhibition of TGf-b axis and action of renin-angiotensin system in human ascending aorta aneurysms426Early signs of microcirculation and macrocirculation abnormalities in prehypertension427Vascular smooth muscle cell-expressed Tie-2 controls vascular tone428Cardiac and vascular remodelling in the development of chronic thrombo-embolic pulmonary hypertension in a novel swine modelBiomarkers431Arrhythmogenic cardiomyopathy: a new, non invasive biomarker432Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?433Design of a high-throughput multiplex proteomics assay to identify left ventricular diastolic dysfunction in diabetes434Monocyte-derived and P-selectin-carrying microparticles are differently modified by a low fat diet in patients with cardiovascular risk factors who will and who will not develop a cardiovascular event435Red blood cell distribution width assessment by polychromatic interference microscopy of thin films in chronic heart failure436Invasive and noninvasive evaluation of quality of radiofrequency-induced cardiac denervation in patients with atrial fibrillation437The effect of therapeutic hypothermia on the level of brain derived neurotrophic factor (BDNF) in sera following cardiopulmonary resustitation438Novel biomarkers to predict outcome in patients with heart failure and severe aortic stenosis439Biological factors linking depression and anxiety to cardiovascular disease440Troponins and myoglobin dynamic at coronary arteries graftingInvasive, non-invasive and molecular imaging443Diet composition effects on the genetic typing of the mouse ob mutation: a micro-ultrasound characterization of cardiac function, macro and micro circulation and liver steatosis444Characterization of pig coronary and rabbit aortic lesions using IV-OCT quantitative analysis: correlations with histologyGene therapy and cell therapy447Enhancing the survival and angiogenic potential of mouse atrial mesenchymal cells448VCAM-1 expression in experimental myocardial infarction and its relation to bone marrow-derived mononuclear cell retentionTissue engineering451Advanced multi layered scaffold that increases the maturity of stem cell-derived human cardiomyocytes452Response of engineered heart tissue to simulated ischemia/reperfusion in the presence of acute hyperglycemic conditions453Serum albumin hydrogels prevent de-differentiation of neonatal cardiomyocytes454A novel paintbrush technique for transfer of low viscosity ultraviolet light curable cyan methacrylate on saline immersed in-vitro sheep heart [O] . V Garcia-Martinez, C Lopez Sanchez, W Hamed, 2016

8. Treatment of Degenerative Diseases of the Spine by Physiotherapy [R] . Koch, W., Lynn, A. 1985

1. Gene and cell therapy based treatment strategies for inflammatory bowel diseases [J] . Sander van der Marel ,Anna Majowicz ,Sander van Deventer . 世界胃肠病理生理学杂志：英文版（电子版） . 2011,第6期

2. Antibody gene therapy: an attractive approach for the treatment of cancers and other chronic diseases [J] . Dexian Zheng . 细胞研究：英文版 . 2007,第4期

3. 运用数据挖掘技术探析火针疗法在神经功能障碍相关疾病中的应用 [C] . 徐晶 ,贾春生 ,王建岭 . 2012‘中医针灸北京论坛 . 2012

4. 相关基因多态性与甲氨蝶呤治疗风湿性疾病疗效及不良反应的相关性研究 [A] . 莫小兰 . 2009